Free Trial
OTCMKTS:QBIO

Q BioMed (QBIO) Stock Price, News & Analysis

Q BioMed logo
$0.0002 0.00 (0.00%)
As of 03/28/2025 11:20 AM Eastern

About Q BioMed Stock (OTCMKTS:QBIO)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.03
Volume
800 shs
Average Volume
79,954 shs
Market Capitalization
$29,019.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Remove Ads
Receive QBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Q BioMed and its competitors with MarketBeat's FREE daily newsletter.

QBIO Stock News Headlines

Orchestra Biomed Reports Q3 2024 Financial Results
Revealed: The Chip Stock Redefining AI as We Know It
In this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech firm poised to disrupt the $1 trillion semiconductor industry. He's the same expert who spotted Apple before the iPhone, Amazon before it dominated retail, and Google before it became a verb. Back then, Wall Street shrugged. They're doing it again—ignoring his latest prediction. But according to his research, what we've seen from AI so far is just the beginning. The real boom is still ahead.
A Powerful New Tool for Biomedical Research
See More Headlines

QBIO Stock Analysis - Frequently Asked Questions

Q BioMed's stock was trading at $0.0002 on January 1st, 2025. Since then, QBIO stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

Q BioMed Inc. (OTCMKTS:QBIO) announced its quarterly earnings data on Wednesday, July, 14th. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.04. The firm earned $0.05 million during the quarter.

Shares of QBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Q BioMed investors own include Intel (INTC), Washington Trust Bancorp (WASH), Cisco Systems (CSCO), Nokia Oyj (NOK), NVIDIA (NVDA), Micron Technology (MU) and NewAge (NBEV).

Company Calendar

Last Earnings
7/14/2021
Today
4/01/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:QBIO
Previous Symbol
NASDAQ:QBIO
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$280,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
104,178,000
Market Cap
$29,019.00
Optionable
Not Optionable
Beta
2.30
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (OTCMKTS:QBIO) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners